Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics
about
Mass spectrometry for the assessment of the occurrence and biological consequences of DNA adductsApplication of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs.Mass spectrometry analysis of nucleosides and nucleotides.Characterization of nucleic acids by tandem mass spectrometry - The second decade (2004-2013): From DNA to RNA and modified sequences.
P2860
Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@ast
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@en
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@nl
type
label
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@ast
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@en
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@nl
prefLabel
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@ast
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@en
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@nl
P2860
P356
P1476
Tandem mass spectrometry for c ...... A with anticancer therapeutics
@en
P2093
Catherine Silvestri
Jennifer S Brodbelt
P2860
P304
P356
10.1002/MAS.21363
P407
P577
2013-01-01T00:00:00Z